History of MOMA

The Department of Molecluar Medicine was established at Aarhus University Hospital Skejby in December 2008 and inauguarated in March 2009.
MOMA moved from the hospital to new, spacious laboratory facilities at Science Center Skejby, right next to the hospital. 
From March,1st 2018 to January 1st 2020 MOMA was part of and managed by the Department of Clinical Biochemistry, Aarhus University Hospital.

MOMA emerged from the Molecular Diagnostic  Laboratory (MDL), that was founded in 1997 - at that time counting just four staff members - as a division of the Department of Clinical Biochemistry, Aarhus University Hospital Skejby.

MDL and MOMA have been providing genetical analyses to clinicians since 1996.

In 2000, the spin-out company Aros Applied Biotechnology A/S was founded, dedicated to microarrays and other biotechnological services. Aros joined Eurofins in 2013.

MOMA's staff has since grown to more than 150 members including six professors, consultants, doctors, researchers, bioinformaticians, medical technologists and students.
In 2005, research groups in bladder, colon and prostate cancer lead by senior researchers were founded, while in 2010 a bioinformatic group was established, which since then has grown to four bioinformatic groups.

From 2003 to 2016 MOMA's Core center for Microarrays has provided its services. It was associated with the Institute for Clinical Medicine at Aarhus University.

A NGS Core Center was established in January 2012 as a collaboration between Aarhus University Hospital, The Faculty of Health at Aarhus University and scientists at MOMA, providing sequencing services to researchers.

Since 2013 MOMA has provided common NGS sequencing services (FNE) to all departments at Aarhus University Hospital.


Staff pictures MDL and MOMA 1996-2019



      MDL 2005  

        MOMA group 2015